Dermatology Tweetorials – Disclosures
Disclosures of Conflict of Interest
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity. The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:| Faculty | Relationship Identified With: |
| Steven Chen | Consultant for digital Media: Pfizer, Novartis |
| Steven Feldman, MD, PhD | Consultant/Advisor: AbbVie; Accordant Company, LLC; Almirall, LLC; Alumis Inc.; Alvotech; Arcutis Biotherapeutics, Inc.; Arena Pharmaceuticals; argenx; Biocon; Boehringer Ingelheim; Bristol-Myers Squibb Company; Dermavant; Forte Biosciences, Inc.; Helsinn; Incyte; Janssen; LEO Pharma; Lilly USA, LLC; Micreos; Mylan; Novartis Pharmaceuticals Corporation; Ono Pharmaceutical CO., LTD.; Ortho Dermatology; Pfizer Inc.; Samsung Biologics; Sanofi; Sun Pharma; UCB; Verrica Pharmaceuticals; Voluntis; vTv Therapeutics
Grant/Research Support: AbbVie; Almirall, LLC; Bristol-Myers Squibb Company; Galderma; Incyte; Janssen; LEO Pharma; Lilly USA, LLC; Novartis Pharmaceuticals Corporation; Ortho Dermatology; Perfect Corp; Pfizer Inc.; Target-Derm; UCB
Speaker: AbbVie; Alvotech; Amgen Inc.; Boehringer Ingelheim; Bristol-Myers Squibb Company; Janssen; LEO Pharma; Lilly USA, LLC; Ortho Dermatology; Regeneron Pharmaceuticals Inc.; Sanofi; Sun Pharma |
| Juan Carlos Ivancevich, M | Consultant: Laboratorios Casasco Argentina, Faes Farma, Spain, Sanofi; Speaker: Laboratorios Casasco Argentina, Laboratorios Bago, Bolivia, Abbott, Ecuador |
| Brian S. Kim, MD, MTR, FAAD | Consultant: Abbvie, Allmirall, Amagma, AstraZeneca, Cara Therapeutics, Galerma, LEO Pharma, Pfizer,Regeneron, Sanofi, Recens Medical, Trevi Therapeutics, Abrax Japan, Granular Therapeutics, Bellus Health, Bristol-Myers Squibb, Daewoong, Eli Lilly, Incyte, OM Pharma, Shaperon, Jannsen, Novartis; Research Grant: Cara Therapeutics and LEO Pharma |
| Jonathan I Silverberg, MD, PhD, MPH | Consultant: Abbvie, Afyx, Aobiome, Arena, Asana, Aslan, BioMX, Biosion, Bluefin, Bodewell, Boehringer- Ingelheim, Cara, Castle Biosciences, Celgene, Connect Biopharma, Dermavant, Dermira, Dermtech, Eli Lilly, Galderma, GlaxoSmithKline, Incyte, Kiniksa, Leo Pharma, Luna, Menlo, Novartis, Optum, Pfizer, RAPT, Regeneron, Sanofi-Genzyme, Shaperon, Sidekick Health, Union Speaker: Abbvie, Eli Lilly, Leo Pharma, Pfizer, Regeneron, Sanofi-Genzyme Institution received grants: Galderma, Pfizer |